Pulse Entdecken nav.journalClub Debatten Trends Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Vanessa Rodrik-Outmezguine | Synapse

VR

Vanessa Rodrik-Outmezguine

PI3K/AKT/mTOR signaling in cancer

Eli Lilly (United States)

About

Research focus

PI3K/AKT/mTOR signaling in cancer

Impact

129 pubs · 4,588 cites · h-index 23

Affiliations

Work Experience

Eli Lilly (United States)

2024 - 2024

Novartis (Switzerland)

2017 - 2023

Memorial Sloan Kettering Cancer Center

2009 - 2023

Novartis (United States)

2019 - 2021

Pediatrics and Genetics

2021 - 2021

Publications